Results 131 to 140 of about 209,966 (285)

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis [PDF]

, 2018
Paloma Millán-Billi, Candela Serra, Ana Alonso Leon, Diego Castillo   +3 more
openalex   +1 more source

Thrombocytopaenia during nintedanib treatment in a patient with idiopathic pulmonary fibrosis [PDF]

, 2020
Yusuke Ochi, Motoyasu Kato, Masahiro Fujioka, Mika Hayashi, Haruhi Takagi, Kazuhisa Takahashi   +5 more
openalex   +1 more source

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study

, 2017
Toby M. Maher, Eunice Oballa, Juliet K. Simpson, Joanne Porte, Anthony Habgood, William A. Fahy, Aiden Flynn, Philip L. Molyneaux, Rebecca Braybrooke, Hrushikesh Divyateja, Helen Parfrey, Doris M. Rassl, Anne‐Marie Russell, Gauri Saini, Elisabetta Renzoni, Anne-Marie R. Duggan, Richard Hubbard, Athol U. Wells, Pauline T. Lukey, Richard P. Marshall, Gísli Jenkins   +20 more
openalex   +2 more sources

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: A randomised controlled exploratory study [PDF]

, 2017
Brindle, Kayleigh, Crooks, Michael G., Fraser, Simon D., Hart, Simon P., Morice, Alyn H., Wright, Caroline E.   +5 more
core   +2 more sources

Precision medicine advances in idiopathic pulmonary fibrosis

EBioMedicine, 2023
T. Karampitsakos, B. Juan-Guardela, A. Tzouvelekis, J. Herazo-Maya   +3 more
semanticscholar   +1 more source

Efectos dun programa de rehabilitación pulmonar en pacientes con fibrosis pulmonar idiopática: unha revisión bibliográfica [PDF]

, 2017
[Resumen] Objetivo. El objetivo principal de la presente revisión bibliográfica es analizar los efectos de un programa de rehabilitación pulmonar en pacientes diagnosticados de fibrosis pulmonar idiopática (FPI). Material y método.
Pérez Díaz, Andrea
core  

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis.

New England Journal of Medicine, 2015

semanticscholar   +1 more source

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

New England Journal of Medicine, 2014
T. King, W. Bradford, S. Castro-Bernardini, E. Fagan, I. Glaspole, M. Glassberg, E. Gorina, P. Hopkins, D. Kardatzke, L. Lancaster, D. Lederer, S. Nathan, C. Pereira, S. Sahn, R. Sussman, J. Swigris, P. Noble   +16 more
semanticscholar   +1 more source

Pirfenidone treatment of idiopathic pulmonary fibrosis

Therapeutics and Clinical Risk Management, 2011
Ye Gan1,2, Erica L Herzog2, Richard H Gomer31Department of Medicine, Central South University, Changsha, Hunan, China; 2Department of Medicine, Yale University School of Medicine, New Haven, CT, USA; 3Department of Biology, Texas A&M University ...
Ye Gan, Erica L Herzog, Richard H Gomer
doaj  

Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study

BMC Pulmonary Medicine
Background Progressive pulmonary fibrosis is the symptomatic, physiological, and radiological progression of interstitial lung diseases. The aim of this study was to examine the relationship between progressive pulmonary fibrosis and demographic ...
Özlem Erçen Diken, Ömür Güngör, Hüseyin Akkaya   +2 more
doaj   +1 more source